Kestra Medical Technologies, Ltd. (KMTS)
Kestra Medical Technologies will go public soon, but the exact IPO date is still unknown.
Stock Price: Pending
IPO price not available yet

KMTS Cash Flow Statement

Millions USD. Fiscal year is May - Apr.
Year Ending
TTM Apr '24 Apr '23
Net Income
-84.85-100.84-86.74
Depreciation & Amortization
12.3712.175.3
Share-Based Compensation
-1.491.21
Other Operating Activities
6.218.238.09
Operating Cash Flow
-66.27-72.24-69.64
Capital Expenditures
-20.49-12.23-13.93
Other Investing Activities
-0.12-0-1.53
Investing Cash Flow
-20.61-12.23-15.46
Dividends Paid
--0.8-0.67
Share Issuance / Repurchase
-75102.11
Debt Issued / Paid
-5.88-5.33
Other Financing Activities
139.81-2.35-
Financing Cash Flow
139.8177.7396.11
Net Cash Flow
52.93-6.7411
Free Cash Flow
-86.76-84.46-83.57
Free Cash Flow Margin
-189.34%-303.66%-1095.27%
Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).